Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ)
CNY 12.29
(-0.32%)
CNY 12.29
(-0.32%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 190.61 Million | 63.06 Million | 622.76 Million | 138.93 Million | 251.15 Million | 326.78 Million |
| Net Income | 249.9 Million | 315.34 Million | 274.67 Million | -434.42 Million | 319.77 Million | 430.5 Million |
| Depreciation & Amortization | 121.15 Million | 99.56 Million | 96.01 Million | 98.67 Million | 98.29 Million | 78.36 Million |
| Deferred income taxes | -17.19 Million | 8.95 Million | -15.63 Million | 48.64 Million | -35.79 Million | -7.56 Million |
| Stock-based compensation | 9.15 Million | - | - | - | - | - |
| Change in working capital | -242.56 Million | -404.31 Million | 134.59 Million | -176.47 Million | -298.95 Million | -225.4 Million |
| Other non-cash items | 37.35 Million | 52.47 Million | 117.48 Million | 651.16 Million | 132.03 Million | 43.32 Million |
| Investing Cash Flow | -743.23 Million | -526.72 Million | -684.82 Million | 203.78 Million | -240.85 Million | -450.77 Million |
| Investments in PPE | -363.05 Million | -267.96 Million | -213.76 Million | -154.43 Million | -128.33 Million | -143.47 Million |
| Acquisitions | 11.04 Million | 601.13 Thousand | 1.54 Million | 185.12 Million | -12.94 Million | -548.45 Million |
| Investment purchases | -810.4 Million | -416.37 Million | -670.55 Million | -355.51 Million | -166.9 Million | -381.09 Million |
| Sales/Maturities of investments | 418.87 Million | 142.63 Million | 200.46 Million | 512.15 Million | 33.68 Million | 600.54 Million |
| Other Investing Activities | -149.21 Thousand | 14.37 Million | -2.52 Million | 16.44 Million | 33.64 Million | 21.7 Million |
| Financing Cash Flow | 841.71 Million | 357.6 Million | -244.35 Million | 159.38 Million | -118.06 Million | 129.28 Million |
| Debt repayment | -246.19 Million | -580.67 Million | -606 Million | -659 Million | -981.79 Million | -598.45 Million |
| Dividends payments | -161.77 Million | -161.78 Million | -160.13 Million | -160.67 Million | -160.67 Million | -177.8 Million |
| Common Stock Repurchased | -2.63 Million | -161.4 Thousand | -51.59 Million | - | -40.02 Million | -60.15 Million |
| Common Stock Issuance | - | 161.4 Thousand | 51.59 Million | - | 40.02 Million | - |
| Other Financing Activities | 767.05 Million | 1.11 Billion | 548.47 Million | 1.01 Billion | 1.06 Billion | 905.55 Million |
| Accounts receivables | -710.08 Million | -427.22 Million | 254.01 Million | 255.35 Million | -244.11 Million | 69.5 Million |
| Accounts payables | 524.36 Million | 43.89 Million | -48.87 Million | -449.25 Million | 66.64 Million | -267.85 Million |
| Inventory | -39.65 Million | -29.94 Million | -54.91 Million | -31.22 Million | -85.68 Million | -19.48 Million |
| Other working capital | -25.73 Million | 8.95 Million | -15.63 Million | 48.64 Million | -35.79 Million | -205.91 Million |
| Cash at beginning of period | 912.23 Million | 1.01 Billion | 1.32 Billion | 819.87 Million | 928.86 Million | 923.5 Million |
| Cash at end of period | 1.2 Billion | 912.23 Million | 1.01 Billion | 1.32 Billion | 819.87 Million | 928.86 Million |
| Capital Expenditure | -363.05 Million | -267.96 Million | -213.76 Million | -154.43 Million | -128.33 Million | -143.47 Million |
| Effect of forex changes on cash | 396.16 Thousand | 3.15 Million | -830.35 Thousand | 397.41 Thousand | -1.22 Million | 65.66 Thousand |
| Net cash flow / Change in cash | 289.49 Million | -102.89 Million | -307.24 Million | 502.5 Million | -108.98 Million | 5.35 Million |
| Free Cash Flow | -172.44 Million | -204.89 Million | 409 Million | -15.5 Million | 122.82 Million | 183.3 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 61.39 Million | 36.11 Million | 51.29 Million | 249.9 Million | -16.22 Million | 70.94 Million |
| Depreciation & Amortization | - | 32.1 Million | 32.1 Million | 121.15 Million | 115.97 Million | -55.56 Million |
| Deferred income taxes | - | - | - | -17.19 Million | - | 88.82 Million |
| Stock-based compensation | - | - | - | 9.15 Million | 9.15 Million | -15.65 Million |
| Change in working capital | - | - | - | -242.56 Million | -775.46 Million | -73.17 Million |
| Other non-cash items | 26.25 Million | 318.86 Million | -130.74 Million | 37.35 Million | 801.53 Million | -23.1 Million |
| Investing Cash Flow | -316.04 Million | 347.94 Million | 88.71 Million | -743.23 Million | -553.83 Million | -251.56 Million |
| Investments in PPE | -49.74 Million | -49.98 Million | -45.81 Million | -363.05 Million | -71.3 Million | -74.53 Million |
| Acquisitions | 35.98 Thousand | 208.75 Thousand | 631.23 Thousand | 11.04 Million | -419.97 Thousand | 27.92 Thousand |
| Investment purchases | -460 Million | -190 Million | -200 Million | -810.4 Million | -500 Million | -180.4 Million |
| Sales/Maturities of investments | 194.38 Million | 587.72 Million | 333.9 Million | 418.87 Million | 21.21 Million | 3.17 Million |
| Other Investing Activities | -692 Thousand | 168.10 | 17.24 | -149.21 Thousand | -3.77 Million | 162.07 Thousand |
| Financing Cash Flow | 27.96 Million | -595.24 Million | -295.19 Million | 841.71 Million | 22.75 Million | 266.63 Million |
| Debt repayment | - | -427.12 Million | -293.83 Million | -246.19 Million | -22.65 Million | -31 Million |
| Dividends payments | - | -169.55 Million | -1.28 Million | -161.77 Million | -2.2 Million | -2.37 Million |
| Common Stock Repurchased | - | - | - | -2.63 Million | -2.63 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 27.96 Million | 1.54 Million | -79.33 Thousand | 767.05 Million | 2.3 Million | 300 Million |
| Accounts receivables | - | - | - | -710.08 Million | -710.08 Million | -128.3 Million |
| Accounts payables | - | - | - | 524.36 Million | - | - |
| Inventory | - | - | - | -39.65 Million | -39.65 Million | 55.13 Million |
| Other working capital | - | - | - | -25.73 Million | -25.73 Million | - |
| Cash at beginning of period | 960.59 Million | 915.8 Million | 1.2 Billion | 912.23 Million | 1.59 Billion | 1.59 Billion |
| Cash at end of period | 760.31 Million | 960.59 Million | 915.8 Million | 1.2 Billion | 1.2 Billion | 1.59 Billion |
| Capital Expenditure | -49.74 Million | -49.98 Million | -45.81 Million | -363.05 Million | -71.3 Million | -74.53 Million |
| Effect of forex changes on cash | -22.89 Thousand | 6110.92 | 2380.37 | 396.16 Thousand | -22.06 Thousand | 367.7 Thousand |
| Net cash flow / Change in cash | -200.27 Million | 44.79 Million | -285.92 Million | 289.49 Million | -396.13 Million | 7.71 Million |
| Free Cash Flow | 37.9 Million | 272.89 Million | -125.26 Million | -172.44 Million | 63.66 Million | -82.25 Million |
AGGI
CMOPF
007280
KP2
UNITEDTE
IVITF